Viewing Study NCT06824103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-27 @ 7:35 AM
Study NCT ID: NCT06824103
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-02-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft vs. Host Disease View
None Chronic Graft vs. Host Disease View
None Corticosteroid-refractory Chronic Graft vs. Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cGvHD View
None GvHD View
None SR-cGvHD View
None ruxolitinib View
None INC424 View
None Chinese adult View
None Pediatric View
None Corticosteroid View
None refractory View